Evidence-Based Knee Injections for the Management of Arthritis

Pain Medicine (United States)

Volumn 13, Issue 6, 2012, Pages 740-753

  Cheng, Olivia T ^a   Souzdalnitski, Dmitri ^a   Vrooman, Bruce ^a   Cheng, Jianguo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hyaluronic Acid (HA); Intraarticular Corticosteroid Injection (IACI); Juvenile Rheumatoid Arthritis (JRA); Knee Injection; Osteoarthritic (OA); Radiation Synovectomy (RSO); Rheumatoid Arthritis (RA)

Indexed keywords

BOTULINUM TOXIN A; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; HYALURONIC ACID; IMMUNOGLOBULIN G; KELIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOSAN POLYSULFATE; POLYNUCLEOTIDE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHENIUM 188; SAMARIUM 153; TANEZUMAB; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE; TROPISETRON; YTTRIUM 90;

ANALGESIC ACTIVITY; ARTHROPLASTY; CONSERVATIVE TREATMENT; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; INJECTION; JUVENILE RHEUMATOID ARTHRITIS; KNEE ARTHRITIS; KNEE PAIN; KNEE SURGERY; OSTEOARTHRITIS; REVIEW; SYNOVECTOMY; SYSTEMATIC REVIEW; THROMBOCYTE RICH PLASMA; VISCOSUPPLEMENTATION;

EID: 84862572784     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01394.x     Document Type: Review

References (101)

1. Hootman JM, Helmick CG. Projections of U.S. prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006;54:226-9.
2. Hootman J, Bolen J, Helmick C, Langmaid G. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2006;55:1089-92.
3. Felson DT, Naimark A, Anderson J, etal. The prevalence of knee osteoarthritis in the elderly. The Framingham osteoarthritis study. Arthritis Rheum 1987;30:914-8.
4. Murphy L, Schwartz TA, Helmick CG, etal. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 2008;59:1207-13.
5. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol 2002;29:1520-30.
6. Holwell EB. Two cases of tuberculous disease of the knee-joint treated by iodoform injections: Recovery. Br Med J 1897;2(1911):397-8.
7. Chou R. Using evidence in pain practice: Part I: Assessing quality of systematic reviews and clinical practice guidelines. Pain Med 2008;9:518-30.
8. Cheng J, Abdi S. Complications of joint, tendon and muscle injections. Tech Reg Anesth Pain Manag 2007;11:141-7.
9. Guyatt G, Gutterman D, Baumann MH, etal. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians Task Force. Chest 2006;129:174-81.
10. Van Boxem K, Cheng J, Patijn J, etal. 11. Lumbosacral radicular pain. Pain Pract 2010;10:339-58.
11. Wallen M, Gillies D. Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006;(1):CD002824.
12. Godwin M, Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician 2004;50:241-8.
13. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: Meta-analysis. BMJ 2004;328:869-70.
14. Habib GS, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol 2010;29:347-56.
15. Brostrom E, Hagelberg S, Haglund-Akerlind Y. Effect of joint injections in children with juvenile idiopathic arthritis: Evaluation by 3D-gait analysis. Acta Paediatr 2004;93:906-10.
16. Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 1999;42:2330-4.
17. Creamer P, Keen M, Zananiri F, etal. Quantitative magnetic resonance imaging of the knee: A method of measuring response to intraarticular treatments. Ann Rheum Dis 1997;56:378-81.
18. Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 2004;31:2507-12.
19. Hepper CT, Halverson JJ, Duncan ST, etal. The efficacy and duration of intraarticular corticosteroid injection for knee osteoarthritis: A systematic review of level I studies. J Am Acad Orthop Surg 2009;17:638-46.
20. Marti P, Molinari L, Bolt IB, Seger R, Saurenmann RK. Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 2008;167:425-30.
21. Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting intraarticular corticosteroids. Ann Rheum Dis 2000;59:233-5.
22. Charalambous C, Paschalides C, Sadiq S, etal. Weight bearing following intraarticular steroid injection of the knee: Survey of current practice and review of the available evidence. Rheumatol Int 2002;22:185-7.
23. Beukelman T, Guevara JP, Albert DA. Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis. Arthritis Rheum 2008;59:1580-8.
24. Gao IK, Leins C, Bohlen H, Heilig B, Lemmel EM. Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis. Z Rheumatol 1998;57:95-100.
25. Blyth T, Stirling A, Coote J, Land D, Hunter JA. Injection of the rheumatoid knee: Does intraarticular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Br J Rheumatol 1998;37:770-2.
26. Habib GS. Systemic effects of intraarticular corticosteroids. Clin Rheumatol 2009;28:749-56.
27. Hunter JA, Blyth TH. A risk-benefit assessment of intraarticular corticosteroids in rheumatic disorders. Drug Saf 1999;21:353-65.
28. Uziel Y, Berkovitch M, Gazarian M, etal. Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: A double blind, randomized, placebo controlled trial. J Rheumatol 2003;30:594-6.
29. Neustadt DH. Intraarticular injections for osteoarthritis of the knee. Cleve Clin J Med 2006;73:897-910.
30. Bannuru RR, Natov NS, Obadan IE, etal. Therapeutic trajectory of hyaluronic acid vs corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Arthritis Rheum 2009;61:1704-11.
31. Bellamy N, Campbell J, Robinson V, etal. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;(2):CD005321.
32. Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: Should your patient opt for hyaluronic acid injection? J Fam Pract 2006;55:669-75.
33. Modawal A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005;54:758-67.
34. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86-A:538-45.
35. Arrich J, Piribauer F, Mad P, etal. Intraarticular hyaluronic acid for the treatment of osteoarthritis of the knee: Systematic review and meta-analysis. CMAJ 2005;172:1039-43.
36. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: A meta-analysis. JAMA 2003;290:3115-21.
37. Zhang W, Moskowitz RW, Nuki G, etal. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62.
38. Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 2001;390:173-81.
39. Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei) 1997;59:99-106.
40. Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (The FLEXX trial). Semin Arthritis Rheum 2009;39:1-9.
41. Jorgensen A, Stengaard-Pedersen K, Simonsen O, etal. Intra-articular hyaluronoan is without clinical effect in knee osteoarthritis: A multicentre, randomized, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 2010;69:1097-102.
42. Vanelli R, Costa P, Rossi SMP, Benazzo F. Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis: A randomized, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc 2010;18:901-7.
43. Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 2001;8:93-101.
44. Shimizu M, Higuchi H, Takagishi K, Shinozaki T, Kobayashi T. Clinical and biochemical characteristics after intraarticular injection for the treatment of osteoarthritis of the knee: Prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci 2010;15:51-6.
45. Saito S, Kotake S. Is there evidence in support of the use of intra-articular hyaluronate in treating rheumatoid arthritis of the knee? A meta-analysis of the published literature. Mod Rheumatol 2009;19:493-501.
46. Tanaka N, Sakahashi H, Sato E, etal. Intraarticular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion. Rheumatol Int 2002;22:151-4.
47. Kroesen S, Schmid W, Theiler R. Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intraarticular injection of hylan G-F 20 (Synvisc). Clin Rheumatol 2000;19:147-9.
48. van der Zant FM, Boer RO, Moolenburgh JD, etal. Radiation synovectomy with (90)Yttrium, (186)Rhenium and (169)Erbium: A systematic literature review with meta-analyses. Clin Exp Rheumatol 2009;27:130-9.
49. Lee EB, Shin KC, Lee YJ, etal. 188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis. Nucl Med Commun 2003;24:689-96.
50. Shin K, Lee JC, Choi HJ, etal. Radiation synovectomy using 188Re-tin colloid improves knee synovitis as shown by MRI in refractory rheumatoid arthritis. Nucl Med Commun 2007;28:239-44.
51. Gedik GK, Ugur O, Atilla B, etal. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 2006;20:183-8.
52. Gedik GK, Ugur O, Atilla B, Dundar S. Is corticosteroid coinjection necessary for radiosynoviorthesis of patients with hemophilia? Clin Nucl Med 2004;29:538-41.
53. Clunie G, Lui D, Cullum I, Ell PJ, Edwards JC. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol 1996;25:360-6.
54. O'Duffy EK, Clunie GP, Lui D, Edwards JC, Ell PJ. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Ann Rheum Dis 1999;58:554-8.
55. Mahowald ML, Singh JA, Dykstra D. Long term effects of intraarticular botulinum toxin A for refractory joint pain. Neurotox Res 2006;9:179-88.
56. Mahowald ML, Krug HE, Singh JA, Dykstra D. Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain. Toxicon 2009;54:658-67.
57. Singh JA, Mahowald ML, Noorbaloochi S. Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial. J Rheumatol 2010;37:2377-86.
58. 3 receptor over-expression in sensory neurons induced by ventral root transection in rats. Pain Med 2011;12:1385-94.
59. Bach-Rojecky L, Salković-Petrisić M, Lacković Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection. Eur J Pharmacol 2010;633:10-4.
60. Bach-Rojecky L, Lackovic Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav 2009;94:234-8.
61. Antonucci F, Rossi C, Gianfrancesci L, Rosetto O, Calleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 2008;28:3689-96.
62. McMahon HT, Foran P, Dolly JO, etal. Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and metenkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem 1992;267:21338-43.
63. Purkiss J, Welch M, Doward S, Foster K. Capsaicin stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms. Biochem Pharmacol 2000;59:1403-6.
64. Morris JL, Jobling P, Gibbins IL. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 2001;281:H2124-32.
65. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005;26:785-93.
66. Bach-Rojecky L, Lackovic Z. Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. Croat Med J 2005;46:201-8.
67. Bach-Rojecky L, Relja M, Lackovic Z. Botulinum toxin type A in experimental neuropathic pain. J Neural Transm 2005;112:215-9.
68. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin induced pain. Pain 2004;107:125-33.
69. Favre-Guilmard C, Auguet M, Chabrier PE. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol 2009;617:48-53.
70. Luvisetto S, Marinelli S, Cobianchi S, Pavone F. Antiallodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Neuroscience 2007;145:1-4.
71. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine vs dexamethasone in chronic arthritis. Pain 1999;83:525-32.
72. Lane NE, Schnitzer TJ, Birbara CA, etal. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010;363:1521-31.
73. Kon E, Buda R, Filardo G, etal. Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010;18:472-9.
74. Samborski W, Stratz T, Mackiewicz S, Muller W. Intraarticular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol 2004;33:51-4.
75. Veale DJ, Reece RJ, Parsons W, etal. Intra-articular primatised anti-CD4: Efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology. Ann Rheum Dis 1999;58:342-9.
76. Bagge E, Geijer M, Tarkowski A. Intraarticular administration of polyclonal immunoglobulin G in rheumatoid arthritis. A double-blind, placebo-controlled pilot study. Scand J Rheumatol 1996;25:174-6.
77. Mease PJ, Hobbs K, Chalmers A, etal. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: A phase 1 dose-escalation safety and tolerability study. Ann Rheum Dis 2009;68:1247-54.
78. Chevalier X, Giraudeau B, Conrozier T, etal. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: A multicenter study. J Rheumatol 2005;32:1317-23.
79. Chevalier X, Goupille P, Beaulieu AD, etal. Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344-52.
80. Yang KG, Raijmakers NJ, van Arkel ER, etal. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage 2008;16:498-505.
81. Huber R, Prestel U, Bloss I, Meyer U, Ludtke R. Effectiveness of subcutaneous injections of a cartilage preparation in osteoarthritis of the knee-A randomized, placebo controlled phase II study. Complement Ther Med 2010;18:113-8.
82. Kumagai K, Shirabe S, Miyata N, etal. Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis-An open clinical trial. BMC Clin Pharmacol 2010;10:1-9.
83. Corbett M, Seifert MH, Hacking C, Webb S. Comparison between local injections of silicone oil and hydrocortisone acetate in chronic arthritis. Br Med J 1970;1(5687):24-5.
84. Kumar M, Dikshit OP. Intra-articular lactic acid solution in osteoarthritis. J Indian Med Assoc 1968;50:420-2.
85. Nissilä M. Osmic acid treatment for rheumatoid synovitis. Ann Clin Res 1975;7:202-4.
86. Huskisson EC, Scott J. Orgotein in osteoarthritis of the knee joint. Eur J Rheumatol Inflamm 1981;4:212-8.
87. Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med 2000;6:68-74, 77-8.
88. Unlu Z, Ay K, Tuzun C. Comparison of intra-articular tenoxicam and oral tenoxicam for pain and physical functioning in osteoarthritis of the knee. Clin Rheumatol 2006;25:54-61.
89. Vajaradul Y. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin Ther 1981;3:336-43.
90. Fioravanti A, Govoni M, La Montagna G, etal. Somatostatin 14 and joint inflammation: Evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 1995;21:97-103.
91. Tejeswar Rao P. Intra-articular chloroquine in rheumatoid and osteoarthritis of knee joint. J Indian Med Assoc 1977;69:193-5.
92. Fujimoto K, Ueno R. Intra-articular treatment of osteoarthrosis of the knee-joint with a mucopolysaccharid-polysulfuric acid ester. Z Orthop Ihre Grenzgeb 1973;111:310-4.
93. Langkilde M, Rossel I. Intra-articular use of cytostatica. (Thio-Tepa, Azetepa and Osmium acid). Acta Rheumatol Scand 1967;13:92-100.
94. Hu JZ, Luo CY, Kang M, etal. Therapeutic effects of intraarticular injection of ligustrazine on knee osteoarthritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006;31:591-4.
95. Avouac J, Vicaut E, Bardin T, Richette P. Efficacy of joint lavage in knee osteoarthritis: Meta-analysis of randomized controlled studies. Rheumatology (Oxford) 2010;49:334-40.
96. Reichenbach S, Rutjes AW, Nüesch E, Trelle S, Jüni P. Joint lavage for osteoarthritis of the knee. Cochrane Database Syst Rev 2010;(5):CD007320.
97. Miller RD. Some recent advances in the symptomatic treatment of osteoarthritis. Calif Med 1950;72:373-6.
98. Loughnan TE, Taverner MG, Webb A. Randomized, double blinded comparative trial of intradermal injections of lignocaine vs N-saline around the knee to relieve pain in patients awaiting total knee replacement. Clin J Pain 2009;25:269-72.
99. Creamer P, Hunt M, Dieppe P. Pain mechanisms in osteoarthritis of the knee: Effect of intraarticular anesthetic. J Rheumatol 1996;23:1031-6.
100. Elsharnouby NM, Eid HE, Abou Elezz NF, Moharram AN. Intraarticular injection of magnesium sulphate and/or bupivacaine for postoperative analgesia after arthroscopic knee surgery. Anesth Analg 2008;106:1548-52.
101. Choi WJ, Hwang SJ, Song JG, etal. Radiofrequency treatment relieves chronic knee osteoarthritis pain: A double-blind randomized controlled trial. Pain 2011;152:481-7.